Site Search

Helicobacter pylori - Insights

Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.

COVID-19 - Insights

Learn more about our comprehensive menu of COVID-19 molecular, serology, and related testing.

GI parasitic disease - Insights

Learn about our focused approach to gastrointestinal disease testing and the identification of the type of parasite present in a sample.

Infectious Disease Pathology at Mayo Clinic Laboratories

We have the knowledge and experience in diagnosing infectious entities and discussing the different options for testing in the clinical microbiology laboratory.

Lung Cancer Testing - Mayo Clinic Laboratories

Mayo Clinic Laboratories innovates at the speed of medical advancement, and offers comprehensive options for diagnostic, prognostic, and predictive lung cancer testing.

Pediatrics - Insights

Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.

Transformative diagnostics - Insights

With a sophisticated laboratory test catalog and thousands of Mayo Clinic experts, we’re here to help you answer the toughest clinical questions.

Inflammatory Bowel Disease - Mayo Clinic Laboratories

Inflammatory bowel disease (IBD) is typically classified as either Crohn's disease or ulcerative colitis based on clinical features, colonoscopy findings, histologic changes, and the anatomical distribution of disease. In some cases,...

Malabsorption - Mayo Clinic Laboratories

Stool testing is a critical component of diagnosing EPI and Mayo Clinic Laboratories offers multiple tests to help clinicians in their work-up of these patients.

Autoimmune GI Dysmotility - Mayo Clinic Laboratories

Identifying GI dysmotility as autoimmune-mediated is extremely important because patients treated with immunotherapy can see a dramatic improvement, going from persistent nausea, vomiting, and weight loss to feeling normal within a few...

Intestinal Infection Testing - Mayo Clinic Laboratories

The gastrointestinal pathogen panel is a multiplex polymerase chain reaction (PCR) test capable of rapidly and qualitatively detecting DNA or RNA of 22 pathogens (13 bacteria, 5 viruses, and 4 parasites).

Resources for patients - Insights

Discover helpful patient resources, including how to request an appointment at Mayo Clinic, test result information, information about diseases and conditions, Symptom Checker, and healthy lifestyle information.

https://x.com/intent/tweet?text=Mayo%20Clinic%20Laboratories:%20https://www.mayocliniclabs.com/test-catalog/print-catalog.html

JavaScript is not available. We’ve detected that JavaScript is disabled in this browser. Please enable JavaScript or switch to a supported browser to continue using x.com. You can see a list of supported browsers in our Help Center....

New test distinguishes between prion disease and other causes of rapidly progressive dementia - Insights

Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.

A Mayo Pathologist's Journey through Paraneoplastic Syndrome and a Double Lung Transplant: Dr. Brad Karon - Insights

After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Years later, pulmonary...

What's New in Quality & Regulatory? (2025) - Insights

Register now – Oct. 14, 2025 - PACE/State of FL - This webinar will provide an overview of recent regulatory changes impacting clinical laboratories. This will include the latest updates to Clinical Laboratory Improvement Amendments (CLIA)...

Featured new tests - Insights

In 2020, Mayo Clinic Laboratories launched more than 100 new tests. Driven by a patient-centered philosophy, our experts, laboratories, and facilities make it possible to develop new tests that transform medicine worldwide.

Neurofilament light chain test helps in diagnosis, treatment, and prognosis of ALS and MS - Insights

By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial...

Revolutionizing Endometrial Cancer Diagnostics - Insights

Endometrial cancer affects thousands annually and ranks as the fourth most common cancer among women in the United States. At the forefront of innovative discoveries in endometrial cancer diagnostics are Mayo Clinic's Department of...

A simpler path to answers for patients with mast cell activation syndrome - Insights

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by...

Renal - Insights

Mayo Clinic Laboratories’ nephrology experts, pathologists, and laboratory scientists uphold the highest standards of renal laboratory care.

About Us - Insights

Mayo Clinic Laboratories isn’t just a reference lab. We’re also the diagnostic lab for a hospital, just like your lab. So we know the many benefits of keeping tests as close to patients as possible.

Pediatric - Insights

Clinic’s commitment to meeting the needs of every patient, from the smallest to the tallest, is central to our approach to pediatric gastroenterology testing. Developed in collaboration with Mayo Clinic’s top-ranked GI experts, our...

Stories - Insights

Beyond the test result Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’

Precision in the pancreas: A new genetic test transforms hereditary pancreatitis diagnosis and care - Insights

Mayo Clinic Laboratories’ newly expanded Hereditary Pancreatitis Gene Panel is transforming how clinicians diagnose and manage a complex, often elusive disease. Developed through close collaboration between lab scientists, genetic...

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Mood disorders - Insights

Our pharmacogenomics (PGx) testing, which is used to inform medication selection and dosing, has the potential to revolutionize medication selection for individuals with treatment-resistant depression.

Lab in action - Insights

Learn how Mayo Clinic Laboratories and hospitals we work with around the world balance strong financial performance and world-class patient care.

https://news.mayocliniclabs.com/file-mc2775-864/

How hospitals can generate long-term financial and clinical value by maintaining their own laboratories Reducing costs, boosting revenue, improving care Hospital-owned labs 2 Contents 3 In some form...

CPT codes and LOINC update: August 2024 - Insights

This page lists updates posted to Mayo Clinic Labs during the month of August.

CPT codes and LOINC update: September 2024 - Insights

This page lists updates posted to Mayo Clinic Labs during the month of September.

search - Mayo Clinic Laboratories

Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...

Blood clots in the heart are common in patients with COVID-19 - Insights

A small but in-depth study conducted a postmortem evaluation of the heart tissue of 15 patients with COVID-19, including the first postmortem cardiac findings of three patients who had cleared the virus.

COVID-19 weekly news: April 25-May 1 2022 - Insights

Topic's include: COVID-19 shines a spotlight on laboratory professionals' vital role in health care, a COVID-19 news update, and mental health needs rise as pandemic fluctuates.

Diagnostic Exploratory Testing - Insights

In this month's "Hot Topic," Nicole Boczek, Ph.D., assistant professor and laboratory director in the Department of Laboratory Medicine and Pathology, and Sarah Barnett, M.S., CGC, discuss diagnostic exploratory testing, explain why it’s...

Sleep Disorder Testing - Mayo Clinic Laboratories

Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients.

Whole genome sequencing - Insights

Check out Mayo Clinic Laboratories’ whole genome testing, a next-generation sequencing assay that interrogates nearly every base pair of an individual’s DNA, including the mitochondrial genome.

Mitochondrial disease - Insights

Learn about our four molecular testing options, which can be used to confirm a diagnosis and identify a specific mitochondrial syndrome.

Colorectal Cancer NGS Testing - Mayo Clinic Laboratories

Our panel was designed to meet current guidelines and remain targeted enough to provide clinically actionable results.

Liquid biopsy offers noninvasive DNA testing for cancer care - Insights

Gang Zheng, M.D., Ph.D., and Aaron Mansfield, M.D., describe Mayo Clinic Laboratories’ liquid biopsy, which analyzes blood samples for genetic information to guide cancer treatment. The circulating tumor DNA assay uses next generation...

MayoComplete Next-Generation Sequencing: Oncology Subpanels - Insights

In this month's "Hot Topic," Kevin Halling, M.D., Ph.D., discusses new next generation sequencing testing for various tumor types and the rationale for the enhancements that were made; reviews gene additions that are now available in each...

NGS Testing for Neuro-Oncology - Mayo Clinic Laboratories

Mayo Clinic is recognized worldwide for providing care for complex diseases including brain tumors. With rapid technological advancements and medical discoveries, the standard approach to genetic testing is evolving.

Lung Cancer NGS Panel - Mayo Clinic Laboratories

Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score - Insights

Antibody Prevalence in Epilepsy and Encephalopathy (APE2 ) score.

Six ways innovative lupus tests are transforming patient and clinician experiences - Insights

The Lupus Foundation of America estimates that at least five million people worldwide have a form of lupus. Yet, the most widely used laboratory tests for patients with this complex condition were developed more than 60 years ago, and...

Modules - Insights

Self-paced modules bring foundational learning to your fingertips through engaging activities and assessments. 

Clinical trial testing support - Insights

Learn more about our clinical testing support, specimen preparation and transportation, billing, and access helpful videos to help you get started.

Previous Programs - Insights

Short recordings surrounding disease diagnosis through new methods in testing and treatment.

Pediatric CNS Disorder Testing - Mayo Clinic Laboratories

We offer a first-of-its-kind profile including only the antibodies that are pertinent to pediatric CNS disorders—all in one evaluation.

Lab Billing, Coding, and Compliance: A 2025 Overview - Insights

PACE/State of FL - Critical topics essential for laboratory billing, coding, and compliance.